Clinical Trial Update: PHARMO Institute Seroquel Safety Study

View source ↗

Summary

A completed PHARMO Institute safety study evaluating Seroquel (quetiapine) across schizophrenia, major depressive disorder, bipolar disorder, and generalized an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Generalized Anxiety Disorder
• Major Depressive Disorder
• Schizophrenia

Drugs mentioned

• SEROQUEL (QUETIAPINE)

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia, Major Depressive Disorder | Status: COMPLETED